
Besunyen Holdings Company Limited
0926.HKHKSEConsumer DefensivePackaged Foods
Latest quote
HK$2.50
+HK$0.05 · +2.04%
0926.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteBesunyen Holdings Company Limited, established in Beijing, China, in 2000, functions as a subsidiary of Foreshore Holding Group Limited. The company's core operations encompass the research, development, production, and distribution of therapeutic tea products and pharmaceutical goods throughout the People's Republic of China. Its product range includes a variety of therapeutic teas, prominently featuring the Besunyen brand, alongside specific offerings such as herbal tea, Besunyen Detox, and Besunyen slimming tea. Furthermore, functional teas, such as Besunyen Fit Tea, are also part of its portfolio. Within its pharmaceutical segment, Besunyen markets LARLLY Orlistat for weight loss and manufactures and sells over-the-counter (OTC) medications, including the Besunyen Orlistat weight-loss capsule. Its products reach consumers via an extensive distribution network that includes OTC pharmacies, retail locations in shopping centers and supermarkets, a network of distributors and sub-distributors, and various online e-commerce channels.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- Headquarters
- CN
- CEO
- Bing Feng
- Listed since
- Sep 29, 2010
- Employees
- 123
Market position
Day range
Current HK$2.50
52-week range
Current HK$2.50
- Open
- HK$2.50
- Previous close
- HK$2.45
- Volume
- 17.5K
- 9.11× average
- Average volume
- 1.92K
- Average daily volume
- Market cap
- 305.66M HKD
- Beta
- 1.18
- Market reference 1
- 50-day average
- HK$2.4162
- +3.47% above average
- 200-day average
- HK$2.467
- +1.34% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 89.41M CNY
- P/E (TTM)
- 11.52×
- P/B (TTM)
- 0.54×
- P/S (TTM)
- 0.49×
- EV / EBITDA
- 1.79×
- Earnings yield
- 7.79%
- Free cash flow yield
- 22.90%
- Dividend yield
- 10.00%
Profitability & efficiency
- Gross margin
- 75.21%
- Operating margin
- 5.53%
- Net margin
- 4.27%
- Return on equity
- 4.36%
- Return on assets
- 3.63%
- Return on invested capital
- 3.64%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 2.98×
- Altman Z-score
- 1.89
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 494.32M CNY | 484.3M CNY | 542.88M CNY | 801.34M CNY | 1.1B CNY |
| Cost of goods sold | 147.74M CNY | 158.46M CNY | 196.66M CNY | 308.75M CNY | 402.6M CNY |
| Gross profit | 346.58M CNY | 325.84M CNY | 346.22M CNY | 492.59M CNY | 698.55M CNY |
| Research and development | 9.5M CNY | 29.36M CNY | 34.92M CNY | 33.87M CNY | 93.1M CNY |
| Selling, general, and administrative | 278.4M CNY | 247.64M CNY | 470.73M CNY | 489.39M CNY | 695.88M CNY |
| Operating expenses | 319.09M CNY | 304.29M CNY | 496.51M CNY | 523.97M CNY | 786.65M CNY |
| Interest income | 364.32K CNY | 7.82M CNY | 5.83M CNY | 1.82M CNY | 11.2M CNY |
| Interest expense | 360.42K CNY | 228K CNY | 2M CNY | 7.65M CNY | 5.42M CNY |
| Depreciation and amortization | 14.8M CNY | 13.29M CNY | 15.73M CNY | 18.28M CNY | 55.54M CNY |
| Operating income | 27.5M CNY | 21.55M CNY | −150.29M CNY | −31.38M CNY | −88.1M CNY |
| Net income | 20.44M CNY | 14.8M CNY | −299.24M CNY | −99.09M CNY | −145.71M CNY |
Company facts updated Aug 24, 2026.
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.25
2025 complete year-71.6% since 2015
HK$0.8794
2,015
HK$2.7059
2,016
HK$0.25
2,025
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 27, 2025 | HK$0.15Semi-Annual | Aug 28, 2025 | Sep 12, 2025 |
Dividend | Jun 18, 2025 | HK$0.10Semi-Annual | Jun 19, 2025 | Jul 7, 2025 |
Dividend | Sep 5, 2024 | HK$0.90Semi-Annual | Sep 6, 2024 | Sep 23, 2024 |
Dividend | May 28, 2021 | HK$0.0375Irregular | Jun 1, 2021 | Jun 16, 2021 |
Dividend | Oct 14, 2019 | HK$0.11Irregular | Oct 16, 2019 | Oct 31, 2019 |
Dividend | May 11, 2016 | HK$0.05Special | — | — |
Ex-dividend Aug 27, 2025
HK$0.15
Semi-Annual
Record Aug 28, 2025 · Payment Sep 12, 2025
Ex-dividend Jun 18, 2025
HK$0.10
Semi-Annual
Record Jun 19, 2025 · Payment Jul 7, 2025
Ex-dividend Sep 5, 2024
HK$0.90
Semi-Annual
Record Sep 6, 2024 · Payment Sep 23, 2024
Ex-dividend May 28, 2021
HK$0.0375
Irregular
Record Jun 1, 2021 · Payment Jun 16, 2021
Ex-dividend Oct 14, 2019
HK$0.11
Irregular
Record Oct 16, 2019 · Payment Oct 31, 2019
Ex-dividend May 11, 2016
HK$0.05
Special
0926.HK peers
Continue in GoAI
Research 0926.HKresearch.disclaimer





